The role of polyunsaturated fatty acids in restoring the aging neuronal membrane

Neurobiology of Aging

Volumn 23, Issue 5, 2002, Pages 843-853

  Yehuda, Shlomo ^a   Rabinovitz, Sharon ^a   Carasso, Ralph L ^b   Mostofsky, David I ^c  

^a BAR ILAN UNIVERSITY   (Israel)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Aging; Essential fatty acids; Neuronal membrane; PUFA

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; ACYL COENZYME A DESATURASE; ARACHIDONIC ACID; BETA ENDORPHIN; CHOLESTEROL; CORTICOTROPIN RELEASING FACTOR; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; GAMMA LINOLENIC ACID; HYDROCORTISONE; ICOSAPENTAENOIC ACID; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; ION CHANNEL; LINOLEIC ACID; LINOLENIC ACID; LINOLEOYL COENZYME A DESATURASE; NEUROTOXIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROSTAGLANDIN E2; PROTIRELIN; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALLERGIC ENCEPHALOMYELITIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN REGION; CALORIC RESTRICTION; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; ENZYME ACTIVITY; FATTY ACID METABOLISM; HIPPOCAMPUS; HUMAN; IMMUNE SYSTEM; LEARNING; LIPID COMPOSITION; LONG TERM POTENTIATION; MEMBRANE FLUIDITY; MEMORY; NERVE CELL MEMBRANE; NERVE FIBER; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PAIN THRESHOLD; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; SLEEP; TASK PERFORMANCE; THERMOREGULATION;

AGED; AGING; CELL MEMBRANE; FATTY ACIDS, UNSATURATED; HUMANS; NEURONS;

EID: 0036752552     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00074-X     Document Type: Article

References (136)

1. Alberghina M., Lupo G., Anfuso C.D., Infarinato S. Differential transport of palmitate through the blood-retina and the blood-brain barrier of the rat. Neurosci. Lett. 171:1994;133-136.
2. Alshuaib W.B., Hasan S.M., Cherian S.P., Mathew M.V., Hasan M.Y., Fahim M.A. Reduced potassium currents in old rat CA1 hippocampal neurons. J. Neurosci. Res. 63:2001;176-184.
3. Angelie E., Bonmartin A., Boudraa A., Gonnaud P.M., Mallet J.J., Sappey-Marinier D. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. AJNR Am. J. Neuroradiol. 22:2001;119-127.
4. Arbogast B.W., Neumann J.K., Arbogast L.Y., Leeper S.C., Kostrzema R.M. Transient loss of serum protective activity following short-term stress: a possible biochemical link between stress and atherosclerosis. J. Psychosom. Res. 38:1994;871-884.
5. Aureli T., Di Cocco M.E., Capuani G., Ricciolini R., Manetti C., Miccheli A.et al. Linoleic acid passage through the blood-brain barrier and a possible effect of age. Neurochem. Res. 19:1994;129-133.
6. Avellini L., Terracina L., Gaiti A. Linoleic acid passage through the blood-brain barrier and a possible effect of age. Neurochem. Res. 19:1994;129-133.
7. Babu P.P. Regional heterogeneity of plasma membrane proteins in rat brain. Biochem. Mol. Biol. Int. 43:1997;1033-1039.
8. Back KW, Bogdanoff MD. Plasma lipid response to leadership, conformity and deviation. In: Leiderman PH, Shapiro D, editors. Psychological approach to social behavior. London: Tavistock Publishers, 1964. p 24-42.
9. Bagger J.P., Botker H.E., Thomassen A., Nielsen T.T. Effects of ranolizine on ischemic threshold coronary sinus blood flow, and myocardial metabolism in coronary artery disease. Cardiovasc. Drugs Ther. 11:1997;479-484.
10. Behan D.P., Grigoriadis D.E., Lovenberg T., Chalmers D., Heinrichs S., Liaw C.et al. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. Mol. Psychiatry. 1:1996;265-277.
11. Bickford P.C., Shukitt-Hale B., Joseph J. Effects of aging on cerebellar noradrenergic functions and motor learning: nutritional interventions. Mech. Ageing Dev. 111:1999;141-154.
12. Bland J.S. The use of complementary medicine for healthy aging. Altern. Ther. Health Med. 4:1998;42-48.
13. Blok W.L., Deslypere J.P., Demacker P.N., van der Ven-Jongekrijg J., Hectors M.P., van der Meer J.W.et al. Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year. Eur. J. Clin. Invest. 27:1997;1003-1008.
14. Bourre J.M., Dumont O., Piciotti M., Clement M., Chaudiere J., Bonneil M.et al. Essentiality of w3 fatty acids for brain structure and function. World Rev. Nutr. 66:1991;103-117.
15. Boesze-Battaglia K., Schimmel R.J. Cell membrane lipid composition and distribution: implications for cell function and lessons learned from photoreceptors and platelets. J. Exp. Biol. 200:1997;2927-2936.
16. Brennan F.X., Cobb C.L., Silbert L.E., Watkins L.R., Maier S.F. Peripheral beta-adrenoreceptors and stress-induced hypercholesterolemia in rats. Phys. Behav. 60:1996;1307-1310.
17. Cambromero J.C., Rivas F.J., Borrell J., Guaza C. Role of arachidonic acid metabolism on corticotropin-releasing factor (CRF)-release induced by interleukin-1 from superfused rat hypothalami. J. Neuroimmunol. 39:1992;57-66.
18. Canonico P.L., Speciale C., Sortino M.A., Cronin M.J., MacLeo R., Scapagnini U. Growth hormone releasing factor (GRF) increases free arachidonate levels in the pituitary; a role for lipoxygenase products. Life Sci. 38:1986;267-272.
19. Caughey G.E., Mantzioris E., Gibson R.A., Cleland L.G., James M.J. The effect on human tumor necrosis factor alpha and interleukin-1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr. 63:1996;116-122.
20. alpha, and decreases IL-6, IL-10 in response to LPS: effects of sesamin on the delta-5 desaturation of omega-6 and omega-3 fatty acids in mice. Prostaglandins Leukot. Essent. Fatty Acids. 58:1998;185-191.
21. Chavali S.R., Forse R.A. Decreased production of interleukin-6 and prostoglandin E2 associated with inhibition of delta-5 desaturation of omega-6 fatty acids in mice fed safflower oil diets supplemented with sesamol. Prostaglandins Leukot. Essent. Fatty Acids. 61:1999;347-352.
22. Cheng Y., Chen M., James-Kracke M., Wixom P., Sun A.Y. Enhanced lipid peroxidation by extracellular ATP in PC12 cells. Neurochem. Res. 21:1996;27-33.
23. Choi J.H., Yu B.P. Brain synaptosomal aging: free radicals and membrane fluidity. Free Radic. Biol. Med. 18:1995;133-139.
24. Clark V.R., Moore C.L., Adams J.H. Cholesterol concentrations and cardiovascular reactivity to stress in African American college volunteers. J. Behav. Med. 21:1998;505-515.
25. Colles S., Wood W.G., Myers-Payne S.C., Igbavboa U., Avdulov N.A., Joseph J.et al. Structure and polarity of mouse brain synaptic plasma membrane: effects of ethanol in vitro and in vivo. Neurosci. Res. 22:1995;117-122.
26. 31P NMR spectroscopy Neurochem. Res. 25:2000;395-399.
27. de Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocrine Rev. 19:1998;269-301.
28. de la Torre J.C., Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol. Res. 15:1993;146-153.
29. Denisova N.A., Cantuti-Castelvetri I., Hassan W.N., Paulson K.E., Joseph J.A. Role of membrane lipids in regulation of vulnerability to oxidative stress in PC12 cells: implication for aging. Free Radic. Biol. Med. 30:2001;671-678.
30. Denisova N.A., Erat S.A., Kelly J.F., Roth G.S. Differential effect of aging on cholesterol modulation of carbachol-stimulated low-K(m) GTPase in striatal synaptosomes. Exp. Gerontol. 33:1998;249-265.
31. Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. Eur. J. Clin. Nutr. 49:1995;508-516.
32. Dietschy J.M., Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12:2001;105-112.
33. Eckert G.P., Cairns N.J., Maras A., Gattaz W.F., Muller W.E. Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 11:2000;181-186.
34. Eckert G.P., Cairns N.J., Muller W.E. Piracetam reverses hippocampal membrane alterations in Alzheimer's disease. J. Neural. Transm. 106:1999;757-761.
35. Eckert G.P., Kirsch C., Muller W.E. Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice. Neuroreport. 12:2001;883-887.
36. 31P MRS study Alcohol. Clin. Exp. Res. 25:2001;89-97.
37. Fadda P., Martellotta M.C., Gessa G.L., Fratta W. Dopamine and opioids interactions in sleep deprivation. Prog. Neuropsychopharmacol. Biol. Psychiat. 17:1993;269-278.
38. Fadda P., Martellotta M.C., De Montis M.G., Gessa G.L., Fratta W. Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats. Neurochem. Int. 20:1992;S153-S156.
39. Farooqui A.A., Horrocks L.A. Lipid peroxides in the free radical pathophysiology of brain diseases. Cell Mol. Neurobiol. 18:1998;599-608.
40. Favreliere S., Stadelmann-Ingrand S., Huguet F., De Javel D., Piriou A., Tallineau C.et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol. Aging. 21:2000;653-660.
41. Fleisher-Berkovich S., Danon A. Effect of corticotropin-releasing factor on prostaglandin synthesis in endothelial cells and fibroblasts. Endocrinology. 136:1995;4068-4072.
42. Gabbita S.P., Butterfield D.A., Hensley K., Shaw W., Carney J.M. Aging and caloric restriction affect mitochondrial respiration and lipid membrane status: an electron paramagnetic resonance investigation. Free Radic. Biol. Med. 23:1997;191-201.
43. Gelfand R.A., Wepsic H.T., Parker L.N., Jadus M.R. Prostaglandin E2 induces up-regulation of murine macrophage beta-endorphin receptors. Immunol. Lett. 45:1995;143-148.
44. Grimble R.F. Dietary lipids and the inflammatory response. Proc. Nutr. Soc. 57:1998;535-542.
45. Ginsberg L., Xuereb J.H., Gershfeld N.L. Membrane instability plasmalogen content and Alzheimer's disease. J. Neurochem. 70:1998;2533-2538.
46. Giorgi P.L., Biraghi M., Kantar A. Effect of desmopressin on rat brain synaptosomal membranes: a pilot study. Curr. Therap. Res. 59:1998;172-178.
47. Hamazaki T., Sawazaki S., Nagasawa T., Nagao Y., Kanagawa Y., Yazawa K. Administration of docosahexaenoic acid influence behavior and plasma catecholamine levels at times of psychological stress. Lipids. 34:1999;S33-S37.
48. Hamazaki T., Sawazaki S., Itomura M., Asaoka E., Nagao Y., Nishimura N.et al. The effect of docosahexaenoic acid on aggression in young adults: a placebo-controlled double-blind study. J. Clin. Invest. 97:1996;1129-1133.
49. 2+-ATPase activity in the brain plasma membrane of rats with increasing age: involvement of brain calcium accumulation. Int. J. Mol. Med. 7:2001;407-411.
50. Horrocks LA, Harder HW. Fatty acids and cholesterol. In: Lajtha A, editor. Handbook of neurochemistry. New York: Plenum Press, 1983. p. 1-16.
51. Huang Y.S., Koba K., Horrobin D.F., Sugano M. Interrelationship between dietary protein, cholesterol and n-6 polyunsaturated fatty acid metabolism. Prog. Lipid Res. 32:1993;123-137.
52. Hughes D.A., Pinder A.C. N-3 polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes and inhibit antigen-presentation in vitro. Clin. Exp. Immunol. 110:1997;516-523.
53. Ilincheta de Boschero M.G., Roque M.E., Salvador G.A., Giusto N.M. Alternative pathways for phospholipid synthesis in different brain areas during aging. Exp. Gerontol. 35:2000;653-668.
54. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 71:2000;S343-S348.
55. Ji L.L., Leeuwenburgh C., Leichtweis S., Gore M., Fiebig R., Hollander J.et al. Oxidative stress and aging. Role of exercise and its influences on antioxidant systems. Ann. N.Y. Acad. Sci. 854:1998;102-117.
56. Joo F. Brain microvascular cyclic nucleotides and protein phosphorylation. In: Pardridge WM, editor. Blood brain barrier, cellular and molecular biology. New York: Raven Press, 1993. p. 267-87.
57. Joseph J.A., Denisova N.A., Fisher D., Shukitt-Hale B., Bickford P., Prior R.et al. Membrane and receptor modifications of oxidative stress vulnerability in aging. Nutritional considerations. Ann. N.Y. Acad. Sci. 854:1998;268-276.
58. Joseph J.A., Denisova N.A., Fisher D., Bickford P., Cao G. Age-related neurodegeneration and oxidative stress: putative nutritional intervention. Neurol. Clin. 16:1998;747-755.
59. Joseph J.A., Denisova N.A., Bielinski D., Fisher D.R., Shukitt-Hale B. Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention. Mech. Ageing Dev. 116:2000;141-153.
60. Joseph J.A., Villalobos-Molinas R., Denisova N.A., Erat S., Strain J. Cholesterol: a two-edged sword in brain aging. Free Radic. Biol. Med. 22:1997;455-462.
61. Karanath S., Lyson K., Aguila M.C., McCann S.M. Effects of lutenizing-hormone, releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release. Neuroimmunomodulation. 2:1995;166-173.
62. Kessler A.R., Yehuda S. Learning-induced changes in brain membrane cholesterol and fluidity: implications for brain aging. Int. J. Neurosci. 28:1985;73-82.
63. Kim J.D., McCarter R.J., Yu B.P. Influence of age, exercise, and dietary restriction on oxidative stress in rats. Aging (Milano). 8:1996;123-129.
64. Kolsch H., Ludwig M., Lutjohann D., Rao M.L. Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17β Neural. Transm. 108:2001;475-488.
65. Kopeikina L.T., Kamper E.F., Siafaka I., Stavridis J. Modulation of synaptosomal plasma membrane-bound enzyme activity through the perturbation of plasma membrane lipid structure by bupivacaine. Anesth. Analg. 85:1997;1337-1343.
66. Kumar V.B., Buddhiraju M., Alshaher M., Flood J.F., Morley J.E. Changes in membrane fatty acids and delta-9 desaturase in senescence accelerated (SAM) mouse hippocampus with aging. Life Sci. 65:1999;1657-1662.
67. Lacroix S., Rivest S. Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain. J. Chem. Neuroanat. 10:1996;53-71.
68. Lutjohann D., Breuer O., Ahlborg G., Nennesmo I., Siden A., Diczfalusy U.et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9799-9804.
69. Lutjohann D., Papassotiropoulos A., Bjorkhem I., Locatelli S., Bagli M., Oehring R.D.et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41:2000;195-198.
70. Lynch C., Mobley W. Comprehensive theory of Alzheimer's disease. The effects of cholesterol on membrane receptor trafficking. Ann. N.Y. Acad. Sci. 924:2000;104-111.
71. Lynch M.A. Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine interleukin-1 beta? Prog. Neurobiol. 56:1998;571-589.
72. Maguire P.A., Druse M.J. The influence of cholesterol on synaptic fluidity dopamine D1 binding and dopamine-stimulated adenylate cyclase. Brain Res. Bull. 23:1989;69-74.
73. Makita K., Falck J.R., Capdevila J.H. Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system. FASEB J. 10:1996;1456-1463.
74. Mallick B.N., Thakkar M., Gangabhagirathi R. Rapid eye movement sleep deprivation decreases membrane fluidity in the rat brain. Neurosci. Res. 22:1995;117-122.
75. Matsmoto K., Yobimoto K., Huong N.T., Abdel-Fattah M., Van Hien T., Watanabe H. Psychological stress-induced enhancement of brain lipid peroxidation via nitric oxide systems and its modulation by anxiolytic and anxiogenic drugs in mice. Brain Res. 839:1999;74-84.
76. Mattson M.P., Duan W., Lee J., Guo Z. Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech. Aging Dev. 122:2001;757-778.
77. McGahon B.M., Clements M.P., Lynch M.A. The ability of aged rats to sustain long-term potentiation is restored when the age-related decrease in membrane arachidonic acid concentration is reversed. Neuroscience. 81:1997;9-16.
78. McGahon B.M., Martin D.S., Horrobin D.F., Lynch M.A. Analysis of the effect of membrane arachidonic acid concentration on modulation of glutamate release by interleukin-1: an age-related study. Exp Gerontol. 33:1998;343-354.
79. McGahon B.M., Martin D.S., Horrobin D.F., Lynch M.A. Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience. 94:1999;305-314.
80. McGahon B.M., Murray C.A., Horrobin D.F., Lynch M.A. Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation. Neurobiol. Aging. 20:1999;643-653.
81. Meehan E., Beauge F., Choquart D., Leonard B.E. Influence of an n-6 polyunsaturated fatty acid-enriched diet on the development of tolerance during chronic ethanol administration in rats. Alcohol Clin. Exp. Res. 1:1995;1441-1446.
82. Mills D.E., Huang Y.S., Narce M., Poisson J.P. Psychosocial stress catecholamines, and essential fatty acid metabolism in rats. Proc. Soc. Exp. Biol. Med. 205:1994;56-61.
83. Mills D.E., Prkachin K.M., Harvey K.A., Ward R.P. Dietary fatty acid supplementation alters stress reactivity and performance in man. J. Hum. Hypertens. 3:1989;111-116.
84. Morrow L.E., McClellan J.L., Klir J.J., Kluger M.J. The CNS site of glucocorticoid negative feedback during LPS- and psychological stress-induced fevers. Am. J. Psychol. 271:1996;732-737.
85. Muller W.E., Eckert G.P., Eckert A. Piracetam: novelty in a unique mode of action. Pharmacopsychiatry. 32:1999;2-9.
86. Murphy M.G., Moak C.M., Rao B.G. Effects of membrane polyunsaturated fatty acids on opiate peptide inhibition of basal and prostaglandin E1-stimulated cyclic AMP formation in intact NIE-115 neurometabolism cells. Biochem. Pharmacol. 36:1987;:4079-4084.
87. Murray C.A., Clements M.P., Lynch M.A. Interleukin-1 induces lipid peroxidation and membrane changes in rat hippocampus: an age-related study. Gerontology. 45:1999;136-142.
88. Murray C.A., Lynch M.A. Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J. Neurosci. 18:1998;2974-2981.
89. Nagy K., Floyd R.A., Simon P., Nagy I. Studies on the effect of iron overload on rat cortex synaptosomal membranes. Biochem. Biophys. Acta. 820:1985;216-222.
90. Nagy K., Nagy V., Bertoni-Freddari C., Nagy I. Alterations of the synaptosomal membrane "microviscosity" in the brain cortex of rats during aging and centrophenoxine treatment. Arch. Gerontol. Geriatr. 2:1983;23-39.
91. 2+ channels. J. Neurosci. 18:1998;3171-3179.
92. O'Donnell E., Vereker E., Lynch M.A. Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms. Eur. J. Neurosci. 12:2000;345-352.
93. Ohno T., Ohinata H., Ogawa K., Kuroshima A. Fatty acid profiles of phospholipids in brown adipose tissue from rats during cold acclimation and repetitive intermittent immobilization: with special reference to docosahexaenoic acid. Jpn. J. Physiol. 46:1996;265-270.
94. Oka T., Aou S., Hori T. Intracerebroventriculaer injection of interleukin-1 beta induces hyperalgesia in rats. Brain Res. 624:1993;61-68.
95. Ongini E., Bonizzoni E., Ferri N., Milani S., Trampus M. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J. Pharm. Exp. Therap. 266:1993;726-731.
96. Ohyama H., Hiramatsu M., Ogawa N., Mori A. Age-related differences in synaptosomal membrane fluidity. Biochem. Mol. Biol. Int. 37:1995;133-140.
97. Petraglia F., Benedetto C., Florio P., D'Ambrogio G., Genazzani A.D., Marozio L.et al. Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decide and on contractile activity of human myometrium in vitro. J. Clin. Endocrinol. Metab. 80:1995;3073-3076.
98. Pu L., Igbavboa U., Wood W.G., Roths J.B., Kier A.B., Spener F.et al. Expression of fatty acid binding proteins is altered in aged mouse brain. Mol. Cell. Biochem. 198:1999;69-78.
99. Rapoport S.I., Chang M.C., Spector A.A. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42:2001;678-685.
100. Regev R., Assaraf Y.G., Eytan G.D. Membrane fluidization by ether other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity andmodulates efflux from multidrug-resistant cells. Eur. J. Biochem. 258:1999;18-24.
101. Rivier C. Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Front. Neuroendocrinol. 16:1995;151-182.
102. Rosenman R.H. Do environmental effects on human emotions cause cardiovascular disorders? ACTA Physiologica Scand. Suppl. 640:1997;133-136.
103. Rossetti R.G., Seiler C.M., DeLuca P., Laposata M., Zurier R.B. Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation. J. Leukot Biol. 62:1997;438-443.
104. Rouseau D., Moreau D., Raederstorff D., Sergiel J.P., Muggli R., Grynberg A. Is a dietary n-3 fatty acid supplement able to influence the cardiac effect of the psychological stress. Mol. Cell. Biochem. 178:1998;353-366.
105. Rudolph I.L., Kelley D.S., Klasing K.C., Erickson K.L. Regulation of cellular differentiation and apoptosis by fatty acids and their metabolites. Nutr. Res. 21:2001;381-393.
106. Salem N. Jr., Niebylski C.D. The nervous system has an absolute molecular species requirement for proper function. Mol. Membr. Biol. 12:1995;131-134.
107. Sawazaki S., Hamazaki T., Yazawa K., Kobayashi M. The effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress: a double blind placebo-controlled study. J. Nutr. Neurosci. Vitaminol. 45:1999;655-665.
108. Singer P., Richterheinrich E. Stress and fatty liver - possible indications for dietary long-chain n-3 fatty acids. Med. Hypotheses. 36:1991;90-94.
109. Sparks D.L., Kuo Y.M., Roher A., Martin T., Lukas R.J. Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation: preliminary observation. Ann. N.Y. Acad. Sci. 903:2000;335-344.
110. Srinivasarao P., Narayanareddy K., Vajreswari A., Rupalatha M., Prakash P.S., Rao P. Influence of dietary fat on the activities of subcellular membrane-bound enzymes from different regions of rat brain. Neurochem. Int. 31:1997;789-794.
111. Stoll S., Scheuer K., Pohl O., Muller W.E. Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry. 29:1996;144-149.
112. Strosznajder J., Chalimoniuk M., Strosznajder R.P., Albanese V., Alberghina M. Arachidonate transport through the blood-retina and blood-brain barrier of the rat during aging. Neurosci. Lett. 209:1996;145-148.
113. Strosznajder J., Samochocki M., Duran M. Aging diminishes serotonin-stimulated arachidonic acid uptake and cholinergic receptor-activated acid release in rat brain cortex membrane. J. Neurochem. 62:1994;1048-1054.
114. Terracina L., Brunetti M., Avellini L., de Medio G.E., Trovarelli G., Gaiti A. Linoleic acid metabolism in brain cortex of aged rats. Ital. J. Biochem. 41:1992;225-235.
115. Terracina L., Brunetti M., Avellini L., de Medio G.E., Trovarelli G., Gaiti A. Arachidonic and palmitic acid utilization in aged rat brain areas. Mol. Cell. Biochem. 115:1992;35-42.
116. Thompson A.B.R., Keelan M., Clandinin M.T. Feeding rats a diet enriched with saturated fatty acids presents the inhibitory effects of acute and chromic ethanol exposure on the in vitro uptake of hexoses and lipids. Biochem. Biophys. Acta. 1084:1991;122-128.
117. Ulmann L., Mimouni V., Roux S., Porsolt R., Poisson J.P. Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. Prostaglandins Leukot. Essent. Fatty Acids. 64:2001;189-195.
118. Urano S., Sato Y., Otonari T., Makabe S., Suzuki S., Ogata M.et al. Aging and oxidative stress in neurodegeneration. Biofactors. 7:1998;103-112.
119. Villeponteau B., Cockrell R., Feng J. Nutraceutical interventions may delay aging and the age-related diseases. Exp. Gerontol. 35:2000;1405-1417.
120. Vreugdenhil M., Bruehl C., Voskuyl R.A., Kang J.X., Leaf A., Wadman W.J. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc. Natl. Acad. Sci. U.S.A. 93:1996;12559-12563.
121. Watanabe T., Clarck W.G., Ceriani G., Lipton J.M. Elevation of plasma ACTH concentration in rabbits made febrile by systemic injection of bacterial endotoxin. Brain Res. 652:1994;201-206.
122. Williams L.L., Kiecolt Glaser J.K., Horrocks L.A., Hillhouse J.T., Glaser R. Quantitative association between altered plasma esterfied omega-6 fatty-acid prosportions. Prostaglandins Leukot. Essent. Fatty Acids. 47:1992;165-170.
123. Yamaguchi K., Hama H. Evaluation for roles of brain prostaglandins in the catecholamine-induced vasopressin secretion in conscious rats. Brain Res. 607:1993;149-153.
124. Yano M., Kishida E., Iwasaki M., Shosuke K., Masuzawa Y. Docosahexaenoic acid and vitamin E can reduce human monocytic U937 cell apoptosis induced by tumor necrosis factor. J. Nutr. 130:2000;1095-1101.
125. Yehuda S., Carasso R.L. Modulation of learning, pain threshold and thermoregulation in the rat by preparations of free purified alpha-linoleic and linoleic acids: determination of optimal n-3 to n-6 ratio. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10345-10349.
126. Yehuda S., Carasso R.L., Mostofsky D.I. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur. J. Pharmacol. 254:1994;193-198.
127. Yehuda S., Carasso R.L., Mostofsky D.I. Essential fatty acid preparation (SR-3) rehabilitates learning deficits induced by AF64A and 5,7-DHT. Neuroreport. 6:1995;511-515.
128. Yehuda S, Rabinovitz S, Mostofsky DI. Effects of essential fatty acids preparation, (SR-3) on brain biochemistry and on behavioral and cognitive functions. In: Yehuda S, Mostofsky DI, editors. Handbook of essential fatty acids biology: biochemistry physiology and behavioral neurobiology. New York: Humana Press, 1997. p. 427-52.
129. Yehuda S., Rabinovitz S., Mostofsky D.I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J. Neurosci. Res. 56:1999;565-570.
130. Yehuda S., Rabinovitz S., Carasso R.L., Mostofsky D.I. Fatty acid mixture counters stress changes in cortisol, cholesterol, and impair learning. Int. J. Neurosci. 101:2000;73-87.
131. Youdim K.A., Martin A., Joseph J.A. Essential fatty acids and the brain: possible health implications. Int. J. Dev. Neurosci. 18:2000;383-399.
132. Yu B.P., Suescun E.A., Yang S.Y. Effect of age-related lipid peroxidation on membrane fluidity and phospholopase A2: modulation by dietary restriction. Mech. Ageing Dev. 65:1992;17-33.
133. Zaidi A., Michaelis M.L. Effects of reactive oxygen species on brain synapticplasma membrane Ca(2+)-ATPase. Free Radic. Biol. Med. 27:1999;810-821.
134. 2+-ATPase in F344/BNF1 rats. Neurobiol. Aging. 19:1998;487-495.
135. Zecca L., Costi P., Mecacci C., Ito S., Terreni M., Sonnino S. Interaction of human substantia nigra neuromelanin with lipids and peptides. J. Neurochem. 74:2000;1758-1765.
136. Zheng Z., Hungund B.L. Effects of acute and chronic ethanol exposure on fatty acid ethyl ester synthases in mouse cerebellar membranes. Addict. Biol. 3:1998;85-90.